Crossmark

Evaluation of formulation on the pharmacokinetics, safety, and tolerability of enavogliflozin in healthy Korean adults

Published Online: 2025-12-27

Authors

Lee, Soyoung

Nah, Jae Jin

Shin, Wonsuk

Kim, Anhye

Yoo, Hyounggyoon
Funding

Funding for this research was provided by:

Daewoong Pharmaceutical Company
License Information

Text and Data Mining valid from 2025-12-27

Version of Record valid from 2025-12-27
More Information

Article History

Received: 11 July 2025

Accepted: 16 December 2025

First Online: 27 December 2025

Declarations

:

: The authors declare no competing interests.

Document is current